Concentrations of IGF-I and IGFBP-3 and pancreatic cancer risk in the European Prospective Investigation into Cancer and Nutrition.
BACKGROUND: Insulin-like growth factors (IGFs) and their binding proteins (BPs) regulate cell differentiation, proliferation and apoptosis, and may have a role in the aetiology of various cancers. Information on their role in pancreatic cancer is limited and was examined here in a case-control study...
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Journal article |
| Language: | English |
| Published: |
2012
|
| _version_ | 1797063240432222208 |
|---|---|
| author | Rohrmann, S Grote, V Becker, S Rinaldi, S Tjønneland, A Roswall, N Grønbæk, H Overvad, K Boutron-Ruault, M Clavel-Chapelon, F Racine, A Teucher, B Boeing, H Drogan, D Dilis, V Lagiou, P Trichopoulou, A Palli, D Tagliabue, G Tumino, R Vineis, P Mattiello, A Rodríguez, L Duell, E Molina-Montes, E |
| author_facet | Rohrmann, S Grote, V Becker, S Rinaldi, S Tjønneland, A Roswall, N Grønbæk, H Overvad, K Boutron-Ruault, M Clavel-Chapelon, F Racine, A Teucher, B Boeing, H Drogan, D Dilis, V Lagiou, P Trichopoulou, A Palli, D Tagliabue, G Tumino, R Vineis, P Mattiello, A Rodríguez, L Duell, E Molina-Montes, E |
| author_sort | Rohrmann, S |
| collection | OXFORD |
| description | BACKGROUND: Insulin-like growth factors (IGFs) and their binding proteins (BPs) regulate cell differentiation, proliferation and apoptosis, and may have a role in the aetiology of various cancers. Information on their role in pancreatic cancer is limited and was examined here in a case-control study nested within the European Prospective Investigation into Cancer and Nutrition. METHODS: Serum concentrations of IGF-I and IGFBP-3 were measured using enzyme-linked immunosorbent assays in 422 cases and 422 controls matched on age, sex, study centre, recruitment date, and time since last meal. Conditional logistic regression was used to compute odds ratios (OR) and 95% confidence intervals (CI) adjusted for confounding variables. RESULTS: Neither circulating levels of IGF-I (OR=1.21, 95% CI 0.75-1.93 for top vs bottom quartile, P-trend 0.301), IGFBP-3 (OR=1.00, 95% CI 0.66-1.51, P-trend 0.79), nor the molar IGF-I/IGFBP-3 ratio, an indicator of free IGF-I level (OR=1.22, 95% CI 0.75-1.97, P-trend 0.27), were statistically significantly associated with the risk of pancreatic cancer. In a cross-classification, however, a high concentration of IGF-I with concurrently low levels of IGFBP-3 was related to an increased risk of pancreatic cancer (OR=1.72, 95% CI 1.05-2.83; P-interaction=0.154). CONCLUSION: On the basis of these results, circulating levels of components of the IGF axis do not appear to be the risk factors for pancreatic cancer. However, on the basis of the results of a subanalysis, it cannot be excluded that a relatively large amount of IGF-1 together with very low levels of IGFBP-3 might still be associated with an increase in pancreatic cancer risk. |
| first_indexed | 2024-03-06T20:56:59Z |
| format | Journal article |
| id | oxford-uuid:3997770d-69cb-4678-ada0-68d22aadeb02 |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-03-06T20:56:59Z |
| publishDate | 2012 |
| record_format | dspace |
| spelling | oxford-uuid:3997770d-69cb-4678-ada0-68d22aadeb022022-03-26T13:56:31ZConcentrations of IGF-I and IGFBP-3 and pancreatic cancer risk in the European Prospective Investigation into Cancer and Nutrition.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:3997770d-69cb-4678-ada0-68d22aadeb02EnglishSymplectic Elements at Oxford2012Rohrmann, SGrote, VBecker, SRinaldi, STjønneland, ARoswall, NGrønbæk, HOvervad, KBoutron-Ruault, MClavel-Chapelon, FRacine, ATeucher, BBoeing, HDrogan, DDilis, VLagiou, PTrichopoulou, APalli, DTagliabue, GTumino, RVineis, PMattiello, ARodríguez, LDuell, EMolina-Montes, EBACKGROUND: Insulin-like growth factors (IGFs) and their binding proteins (BPs) regulate cell differentiation, proliferation and apoptosis, and may have a role in the aetiology of various cancers. Information on their role in pancreatic cancer is limited and was examined here in a case-control study nested within the European Prospective Investigation into Cancer and Nutrition. METHODS: Serum concentrations of IGF-I and IGFBP-3 were measured using enzyme-linked immunosorbent assays in 422 cases and 422 controls matched on age, sex, study centre, recruitment date, and time since last meal. Conditional logistic regression was used to compute odds ratios (OR) and 95% confidence intervals (CI) adjusted for confounding variables. RESULTS: Neither circulating levels of IGF-I (OR=1.21, 95% CI 0.75-1.93 for top vs bottom quartile, P-trend 0.301), IGFBP-3 (OR=1.00, 95% CI 0.66-1.51, P-trend 0.79), nor the molar IGF-I/IGFBP-3 ratio, an indicator of free IGF-I level (OR=1.22, 95% CI 0.75-1.97, P-trend 0.27), were statistically significantly associated with the risk of pancreatic cancer. In a cross-classification, however, a high concentration of IGF-I with concurrently low levels of IGFBP-3 was related to an increased risk of pancreatic cancer (OR=1.72, 95% CI 1.05-2.83; P-interaction=0.154). CONCLUSION: On the basis of these results, circulating levels of components of the IGF axis do not appear to be the risk factors for pancreatic cancer. However, on the basis of the results of a subanalysis, it cannot be excluded that a relatively large amount of IGF-1 together with very low levels of IGFBP-3 might still be associated with an increase in pancreatic cancer risk. |
| spellingShingle | Rohrmann, S Grote, V Becker, S Rinaldi, S Tjønneland, A Roswall, N Grønbæk, H Overvad, K Boutron-Ruault, M Clavel-Chapelon, F Racine, A Teucher, B Boeing, H Drogan, D Dilis, V Lagiou, P Trichopoulou, A Palli, D Tagliabue, G Tumino, R Vineis, P Mattiello, A Rodríguez, L Duell, E Molina-Montes, E Concentrations of IGF-I and IGFBP-3 and pancreatic cancer risk in the European Prospective Investigation into Cancer and Nutrition. |
| title | Concentrations of IGF-I and IGFBP-3 and pancreatic cancer risk in the European Prospective Investigation into Cancer and Nutrition. |
| title_full | Concentrations of IGF-I and IGFBP-3 and pancreatic cancer risk in the European Prospective Investigation into Cancer and Nutrition. |
| title_fullStr | Concentrations of IGF-I and IGFBP-3 and pancreatic cancer risk in the European Prospective Investigation into Cancer and Nutrition. |
| title_full_unstemmed | Concentrations of IGF-I and IGFBP-3 and pancreatic cancer risk in the European Prospective Investigation into Cancer and Nutrition. |
| title_short | Concentrations of IGF-I and IGFBP-3 and pancreatic cancer risk in the European Prospective Investigation into Cancer and Nutrition. |
| title_sort | concentrations of igf i and igfbp 3 and pancreatic cancer risk in the european prospective investigation into cancer and nutrition |
| work_keys_str_mv | AT rohrmanns concentrationsofigfiandigfbp3andpancreaticcancerriskintheeuropeanprospectiveinvestigationintocancerandnutrition AT grotev concentrationsofigfiandigfbp3andpancreaticcancerriskintheeuropeanprospectiveinvestigationintocancerandnutrition AT beckers concentrationsofigfiandigfbp3andpancreaticcancerriskintheeuropeanprospectiveinvestigationintocancerandnutrition AT rinaldis concentrationsofigfiandigfbp3andpancreaticcancerriskintheeuropeanprospectiveinvestigationintocancerandnutrition AT tjønnelanda concentrationsofigfiandigfbp3andpancreaticcancerriskintheeuropeanprospectiveinvestigationintocancerandnutrition AT roswalln concentrationsofigfiandigfbp3andpancreaticcancerriskintheeuropeanprospectiveinvestigationintocancerandnutrition AT grønbækh concentrationsofigfiandigfbp3andpancreaticcancerriskintheeuropeanprospectiveinvestigationintocancerandnutrition AT overvadk concentrationsofigfiandigfbp3andpancreaticcancerriskintheeuropeanprospectiveinvestigationintocancerandnutrition AT boutronruaultm concentrationsofigfiandigfbp3andpancreaticcancerriskintheeuropeanprospectiveinvestigationintocancerandnutrition AT clavelchapelonf concentrationsofigfiandigfbp3andpancreaticcancerriskintheeuropeanprospectiveinvestigationintocancerandnutrition AT racinea concentrationsofigfiandigfbp3andpancreaticcancerriskintheeuropeanprospectiveinvestigationintocancerandnutrition AT teucherb concentrationsofigfiandigfbp3andpancreaticcancerriskintheeuropeanprospectiveinvestigationintocancerandnutrition AT boeingh concentrationsofigfiandigfbp3andpancreaticcancerriskintheeuropeanprospectiveinvestigationintocancerandnutrition AT drogand concentrationsofigfiandigfbp3andpancreaticcancerriskintheeuropeanprospectiveinvestigationintocancerandnutrition AT dilisv concentrationsofigfiandigfbp3andpancreaticcancerriskintheeuropeanprospectiveinvestigationintocancerandnutrition AT lagioup concentrationsofigfiandigfbp3andpancreaticcancerriskintheeuropeanprospectiveinvestigationintocancerandnutrition AT trichopouloua concentrationsofigfiandigfbp3andpancreaticcancerriskintheeuropeanprospectiveinvestigationintocancerandnutrition AT pallid concentrationsofigfiandigfbp3andpancreaticcancerriskintheeuropeanprospectiveinvestigationintocancerandnutrition AT tagliabueg concentrationsofigfiandigfbp3andpancreaticcancerriskintheeuropeanprospectiveinvestigationintocancerandnutrition AT tuminor concentrationsofigfiandigfbp3andpancreaticcancerriskintheeuropeanprospectiveinvestigationintocancerandnutrition AT vineisp concentrationsofigfiandigfbp3andpancreaticcancerriskintheeuropeanprospectiveinvestigationintocancerandnutrition AT mattielloa concentrationsofigfiandigfbp3andpancreaticcancerriskintheeuropeanprospectiveinvestigationintocancerandnutrition AT rodriguezl concentrationsofigfiandigfbp3andpancreaticcancerriskintheeuropeanprospectiveinvestigationintocancerandnutrition AT duelle concentrationsofigfiandigfbp3andpancreaticcancerriskintheeuropeanprospectiveinvestigationintocancerandnutrition AT molinamontese concentrationsofigfiandigfbp3andpancreaticcancerriskintheeuropeanprospectiveinvestigationintocancerandnutrition |